Six-Year Results From a Phase I/II Trial for Hypofractionated Accelerated Partial Breast Irradiation Using a 2-Day Dose Schedule
Conclusions:
Hypofractionated 2-day APBI using brachytherapy resulted in excellent clinical outcomes with acceptable chronic toxicities.
Source: American Journal of Clinical Oncology - Category: Cancer & Oncology Tags: Original Articles: Breast Source Type: research
More News: Brachytherapy | Breast Cancer | Cancer | Cancer & Oncology | Clinical Trials | Mammography | Orthopaedics | Skin | Toxicology